BioRemind IVS: Financial statements 2019
CVR: 36733241
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
BioRemind IVS (CVR 36733241) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -2,609 and a net result of DKK -2,609 compared with DKK -6,789 the year before. Equity in the 2019 report amounted to DKK -8,613.
- Gross Profit
- DKK -2,609
- Profit/Loss
- DKK -2,609
- Equity
- DKK -8,613
- Total Assets
- DKK 18,887
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -3 t. | -3 t. | -9 t. | - |
| 2018 | - | -6 t. | -7 t. | -6 t. | - |
| 2017 | - | -5 t. | -6 t. | 785 | - |
| 2016 | - | -10 t. | -11 t. | -24 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
BioRemind IVS has published its annual report for 2018. Gross profit came to DKK -6,244, and the net result was DKK -6,789.
About BioRemind IVS
BioRemind IVS was a Danish company of the type Iværksætterselskab based in Aarhus N, founded in 2015. The company has been dissolved on 20 February 2021. The company was registered under the industry Anden udgivelse af software. In 2019, the company reported a gross profit of DKK -2,609 and a net result of DKK -2,609 compared with DKK -6,789 the year before. Equity in the 2019 report amounted to DKK -8,613.